Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade
- PMID: 1516563
- DOI: 10.1080/07435809209035402
Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade
Abstract
The increase in aldosterone secretion that occurs in response to Angiotensin II (AII) is enhanced when normal humans are in external balance on a low salt diet. The responsible mechanism has not been identified. Angiotensin converting enzyme inhibition reduces blood levels of AII and aldosterone, but does not decrease PRA or AI and does not modify adrenal responsiveness to AII in the sodium-depleted state. This study was designed to assess the possibility that the enhanced adrenal response reflects plasma renin activity (PRA), plasma AI concentration, or catecholamines acting via a beta adrenergic receptor. Nine healthy males were studied when in balance on a high sodium intake (200 mmol Na/day), a low sodium diet (10 mmol Na) and after 4 days of beta adrenergic blockade with either nadolol or propranolol. The adequacy of beta adrenergic blockade was assessed with a postural stimulus and significant blockade was achieved, somewhat more with nadolol (40 mg/day) than with propranolol (Inderal LA, 80 mg every 12 hrs). Beta blockade enhanced the renal vascular and pressor response to AII but did not modify the adrenal response to posture or to AII. This study confirms the role for AII levels in the modulation of renal vascular and pressor responses to AII and rules out a role for PRA, AI, or catecholamines acting via a beta adrenergic receptor in the modulation of adrenal responsiveness to AII.
Similar articles
-
Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.Hypertension. 1984 Jan-Feb;6(1):92-9. doi: 10.1161/01.hyp.6.1.92. Hypertension. 1984. PMID: 6198274
-
Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.J Clin Endocrinol Metab. 1983 Oct;57(4):764-70. doi: 10.1210/jcem-57-4-764. J Clin Endocrinol Metab. 1983. PMID: 6309884
-
The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.Am J Hypertens. 1999 Apr;12(4 Pt 1):348-55. Am J Hypertens. 1999. PMID: 10232494 Clinical Trial.
-
The role of angiotensin II receptors in vascular regulation.J Cardiovasc Pharmacol. 1984;6 Suppl 4:S575-86. doi: 10.1097/00005344-198406004-00004. J Cardiovasc Pharmacol. 1984. PMID: 6083400 Review.
-
Role of angiotensin in the regulation of renal response to proteins.Semin Nephrol. 1995 Sep;15(5):396-404. Semin Nephrol. 1995. PMID: 8525141 Review.
Cited by
-
The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism.Front Pharmacol. 2021 May 13;12:684111. doi: 10.3389/fphar.2021.684111. eCollection 2021. Front Pharmacol. 2021. PMID: 34054559 Free PMC article. Review.
-
Laboratory investigation of primary aldosteronism.Clin Biochem Rev. 2010 May;31(2):39-56. Clin Biochem Rev. 2010. PMID: 20498828 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
